ArticleClinical pharmacology and therapeutics2022

A Quantitative Modeling and Simulation Framework to Support Candidate and Dose Selection of Anti-SARS-CoV-2 Monoclonal Antibodies to Advance Bamlanivimab Into a First-in-Human Clinical Trial.

Emmanuel Chigutsa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.